Subscribe to Newsletter
Business & Regulation Business Practice, Packaging, Standards & Regulation, Trends & Forecasts

Let’s Get Ready to Serialize!

The US and EU serialization deadlines are both less than a year away, with the EU Falsified Medicines (FMD) Directive coming into force on February 9, 2019 and the US Drug Supply Chain Security Act (DSCSA) coming into force on November 27, 2018 – the latter already having been delayed by one year. So how prepared are pharma companies?

Tracelink surveyed 660 companies across segments of the supply chain, including 174 drugmakers, to find out. In their Global Drug Supply, Safety and Traceability Report, they found that only one-third of respondents believe they are “very ready” for serialization. The data also revealed that no single company has actually completed all the basic steps for serialization readiness. According to the authors, the survey proves “that the companies who feel very ready are considerably ‘less ready’ than they think.”

Receive content, products, events as well as relevant industry updates from The Medicine Maker and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

  1. TraceLink, “TraceLink Publishes Full Analysis from the Global Drug Supply, Safety and Traceability Report, Industry’s Largest Survey on Life Science Companies’ Readiness for Serialization Deadlines” (2018). Available at:
  2. Accessed April 10, 2018.
About the Author
James Strachan

Over the course of my Biomedical Sciences degree it dawned on me that my goal of becoming a scientist didn’t quite mesh with my lack of affinity for lab work. Thinking on my decision to pursue biology rather than English at age 15 – despite an aptitude for the latter – I realized that science writing was a way to combine what I loved with what I was good at.


From there I set out to gather as much freelancing experience as I could, spending 2 years developing scientific content for International Innovation, before completing an MSc in Science Communication. After gaining invaluable experience in supporting the communications efforts of CERN and IN-PART, I joined Texere – where I am focused on producing consistently engaging, cutting-edge and innovative content for our specialist audiences around the world.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine